These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3961318)

  • 1. Tables of the number of patients required in clinical trials using the logrank test.
    Stein RA
    Stat Med; 1986; 5(1):97-8. PubMed ID: 3961318
    [No Abstract]   [Full Text] [Related]  

  • 2. Tables of the number of patients required in clinical trials using the logrank test.
    Freedman LS
    Stat Med; 1982; 1(2):121-9. PubMed ID: 7187087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of logrank tests and group sequential methods at fixed calendar times.
    DeMets DL; Gail MH
    Biometrics; 1985 Dec; 41(4):1039-44. PubMed ID: 4096915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and analysis of group sequential logrank tests in maximum duration versus information trials.
    Kim K; Boucher H; Tsiatis AA
    Biometrics; 1995 Sep; 51(3):988-1000. PubMed ID: 7548714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An asymptotic analysis of the logrank test.
    Strawderman RL
    Lifetime Data Anal; 1997; 3(3):225-49. PubMed ID: 9384654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Conservative experimental groups in clinical comparative trials. Tables providing the minimum number of patients].
    Lehmann EH; Sandvik H
    Tidsskr Nor Laegeforen; 1996 Aug; 116(18):2183-5. PubMed ID: 8801663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stopping rules for clinical trials incorporating clinical opinion.
    Freedman LS; Lowe D; Macaskill P
    Biometrics; 1984 Sep; 40(3):575-86. PubMed ID: 6518241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Routine statistics and clinical trials.
    Wahrendorf J
    Biometrics; 1983 Mar; 39(1):269-73. PubMed ID: 6871357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of unequal allocation in survival trials.
    Sposto R; Krailo MD
    Stat Med; 1987 Mar; 6(2):119-25. PubMed ID: 3589241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating treatment effects in clinical trials subject to regression to the mean.
    Senn SJ; Brown RA
    Biometrics; 1985 Jun; 41(2):555-60. PubMed ID: 4027329
    [No Abstract]   [Full Text] [Related]  

  • 11. Exact confidence intervals following a group sequential test.
    Tsiatis AA; Rosner GL; Mehta CR
    Biometrics; 1984 Sep; 40(3):797-803. PubMed ID: 6518248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating maximum power losses in survival studies with nonstratified randomization.
    Palta M
    Biometrics; 1985 Jun; 41(2):497-504. PubMed ID: 4027324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated significance tests for clinical trials with a fixed number of patients and variable follow-up.
    Armitage P; Stratton IM; Worthington HV
    Biometrics; 1985 Jun; 41(2):353-9. PubMed ID: 4027318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the mathematical basis of Zelen's prerandomized designs.
    Brunner E; Neumann N
    Methods Inf Med; 1985 Jul; 24(3):120-30. PubMed ID: 4033442
    [No Abstract]   [Full Text] [Related]  

  • 15. Methodological issues in cancer clinical trials: the comparison of therapies.
    Gehan EA
    Biomed Pharmacother; 1988; 42(3):161-5. PubMed ID: 3179400
    [No Abstract]   [Full Text] [Related]  

  • 16. Statistical analysis of a clinical trial in orthostatic hypotension--a nonparametric approach.
    Haux R; Immich H; Schumacher M
    Methods Inf Med; 1987 Jan; 26(1):47-52. PubMed ID: 3561258
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical studies between empiricism and biometrics].
    Röding H
    Zentralbl Chir; 1991; 116(12):767-70. PubMed ID: 1833932
    [No Abstract]   [Full Text] [Related]  

  • 18. Approaches to sample size estimation in the design of clinical trials--a review.
    Makuch R
    Stat Med; 1985; 4(2):247. PubMed ID: 4023483
    [No Abstract]   [Full Text] [Related]  

  • 19. Testing for the existence of a desirable dose combination.
    Hung HM; Chi GY; Lipicky RJ
    Biometrics; 1993 Mar; 49(1):85-94. PubMed ID: 8513112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Planning and monitoring of equivalence studies.
    Durrleman S; Simon R
    Biometrics; 1990 Jun; 46(2):329-36. PubMed ID: 2194579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.